Associations of obesity markers, insulin, and sex hormones with HDL- cholesterol levels in Turkish and German individuals

Atherosclerosis

Volumn 145, Issue 1, 1999, Pages 147-156

  Hergenç, Gulay ^a   Schulte, Helmut ^b   Assmann, Gerd ^b   Von Eckardstein, Arnold ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Androgens; Cardiovascular risk factors; Leptin; Lp(a); SHBG; Testosterone

Indexed keywords

APOLIPOPROTEIN B; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANDROGEN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ESTRADIOL BLOOD LEVEL; ETHNOLOGY; FEMALE; GERMANY; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; TURKEY (REPUBLIC);

ADULT; ANTHROPOMETRY; BLOOD PRESSURE; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; ESTRADIOL; FEMALE; GERMANY; GONADAL STEROID HORMONES; HUMANS; INSULIN; LEPTIN; MALE; MIDDLE AGED; OBESITY; PROTEINS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TURKEY;

EID: 0033048634     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00027-1     Document Type: Article

References (40)

1. Gordon D., Riflkind B.M. Current concepts: high density lipoproteins: the clinical implications of recent studies. N. Engl. J. Med. 321:1989;1311-1315.
2. Heller D.A., de Faire U., Pedersen N.L., Dahlen G., McClearn G.E. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328:1993;1150-1156.
3. Lyu L.C., Shieh M.J., Ordovas J.M., Lichtenstein A.H., Wilson P.W., Schaefer E.J. Plasma lipoprotein and apolipoprotein levels in Tapei and Framingham. Arterioscler. Thromb. 13:1993;1429-1440.
4. Patsch W., Sharrett A.R., Sorlie P.D., Davis C.E., Brown S.A. The relation of high density lipoprotein cholesterol and its subfractions to apoliprotein A-I and fasting triglycerides: the role of environmental factors: the atherosclerosis risk communities (ARIC) Study. Am. J. Epidemiol. 136:1992;546-557.
5. Heath G.W., Macera C.A., Croft J.B., Mace M.L., Gillette T., Wheeler F.C. Correlates of high-density lipoprotein cholesterol in black and white women. Am. J. Public Health. 84:1994;98-101.
6. Rubins H.B., Robins S.J., Collins D. et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of veterans affairs HDL intervention trial study group. Am. J. Cardiol. 75:1995;1196-1201.
7. Morrison J.A., Sprecher D., McMahon R.P., Simon J., Schreiber G.B., Khoury P.R. Obesity and high-density lipoprotein cholesterol in black and white 9- and 10-year-old girls: the national heart, lung, and blood institute growth and health study. Metabolism. 45:1996;469-474.
8. Stern M.P., Rosenthal M., Haffner S.M., Hazuda H.P., Franco L.J. Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans. The San Antonio Heart Study. Am. J. Epidemiol. 120:1984;834-851.
9. Brown SA, Hutchinson R, Morrisett J, Boerwinkle E, Davies CE, Gotto AM Jr, Patsch W. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb 1993; 13: 1139-1158.
10. Koycu B., Kara T., Camlidag O., Aydinli R., Vershuren W., van Montfrans G.A. Risk factors for cardiovascular diseases in Turks in Amsterdam and in Ankara. Ned. Tjdschr. Geneekd. 141(18):1997;882-888.
11. Mahley R.W., Palaoglu K.E., Atak Z. et al. Turkish heart study: lipids, lipoproteins, and apolipoproteins. J. Lipid. Res. 36:1995;839-859.
12. Luttmann S, von Eckardstein, Wei W, Funke H, Kohler E, Mahley RW, Assmann G. Electrophoretic screening for genetic variation in apolipoprotein C-111: identification of a novel apo C-III variant, apo C III(Asp45→Asn), in a Turkish patient. J Lipid Res 1994, 35: 1431-1440.
13. Stern MP. Diabetes and cardiovascular disease. The common soil hypothesis. Diabetes 1995: 44; 369-374.
14. Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988: 37; 1595-1607.
15. Després JP, Marette A. Relation of components of insulin resistance to coronary disease risk. Curr Opin Lipidol 1994.5: 274-289.
16. Elbein S.C. An update on the genetic basis of type 2 diabetes. Curr. Opin. Endocrinol. Diab. 5:1998;116-125.
17. Defronzo R, Bonadonna R, Ferranini E. Pathogenesis of NIDDM. Alberti K, Zimmet P, DeFronzo R International Textbook of Diabetes Mellitus. 1997;635-712 Wiley, New York.
18. Fulton-Kehoe D.L., Eckel R.H., Shetterly S.M., Hamman R.F. Determinants of total high density lipoprotein cholesterol and high density lipoprotein subfraction levels among Hispanic and non-Hispanic white persons with normal glucose tolerance: the San Luis Valley Diabetes Study. J. Clin. Epidemiol. 45:1992;1191-1200.
19. Lobo R.A. Clinical review 27: effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. J. Clin. Endocrinol. Metab. 73:1991;925-930.
20. von Eckardstein A. Androgens, cardiovascular risk factors and atherosclerosis. Nieschlag E., Behre H.M. Testosterone: action, deficiency, substitution. 2nd Edition:1998;229-258 Springer-Verlag, Berlin.
21. Pugeat M., Moulin P., Cousin P., Fimbel S., Nicolas M.H., Crave J.C., Lejeune H. Interrelations between SHBG, plasma lipoproteins and cardiovascular risk. J. Steroid. Biochem. Mol. Biol. 53:1995;567-572.
22. Tchernof A., Labrie F., Belanger A. et al. Relationships between endogenous steroid hormone, sex hormone-binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variables. Atherosclerosis. 133:1997;235-244.
23. Jaquish C.E., Mahaney M.C., Blangero J., Haffner S.M., Stern M.P., Maccluer J.W. Genetic correlations between lipoprotein phenotypes and indicators of sex hormone levels in Mexican Americans. Atherosclerosis. 122:1996;117-125.
24. Assmann G, Schulte H. Results and Conclusions of the Prospective Cardiovascular Münster (PROCAM) Study. In: Assmann G, editor. Lipid metabolism disorders and coronary heart disease. Primary prevention, diagnosis, and therapy guidelines for general practice. 2nd Edition. MMV Medizin Verlag, Munich 1993: 19-67.
25. Anonymous. Standardization of blood pressure readings. Am Heart J 1939;18:95.
26. Friedewald W.T., Levy J., Fredrickson D.S. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:1972;499-502.
27. Sandkamp M, Tambyrarajah B, Schriewer H, Assmann G. Simplified turbidimetric determination of apolipoproteins A-I, A-II and B. J Clin Chem Clin Biochem 1988.26: 685-688.
28. Sandkamp M., Funke H., Schulte H., Köhler E., Assmann G. Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. Clin. Chem. 38:1990;20-25.
29. Nie NH. SPSSX User's Guide. New York: McGraw-Hill, 1983.
30. Couillard C., Lamarche B., Tchernof A., Prud'homme D., Tremblay A., Bouchard C., Moorjani S., Nadeau A., Lupien P.J., Despres J.P. Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome. Metabolism. 45:1996;882-888.
31. Temme EH, Mensink, Hornstra G. Comparison of the effects of diet enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr. 1996;63:897-903.
32. Savolainen MJ, Kesaniemi, YA. Effects of alcohol on lipoproteins in relation to coronary heart disease. Curr Opin Lipidol.1995: 243-250.
33. Rosenbaum M, Leibel RL, Hirsch JH. Obesity. N Engl J Med 1997: 337; 396-406.
34. Lönnquist F., Schalling M. Role of leptin and its receptor in human obesity. Curr. Opin. Endocrinol. Diabetes. 4:1997;164-171.
35. Guerra R., Wang J., Grundy S.M., Cohen J.C. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94:1997;4532-4537.
36. Vega G.L., Clark L.T., Tang A., Marcovina S., Grundy S.M., Cohen J.C. Hepatic lipase activity is lower in African American men than in white American men: effects of 5′ flanking polymorphism in the hepatic lipase gene (LIPC). J. Lipid Res. 39:1998;228-232.
37. Yamashita S, Sakai N, Hirano K, Arai T, Ishigami M, Maruyama T, Matsuzawa Y. Molecular genetics of plasma cholesteryl ester transfer protein. Curr Opin Lipidol 1997, 8: 101-110.
38. Funke H., Wiebusch H., Fuer L., Muntoni S., Schulte H., Assmann G. Identification of mutations in the cholesteryl ester transfer protein in Europeans with elevated high density lipoprotein cholesterol. Circulation. 90:1994;1-241.
39. Nordestgaard BG, Abildgaard S, Wittrup HH, Steffensen R, Jensen G, Tybjaerg-Hansen A. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation 1997; 96: 1737-1744.
40. Ehrenborg E., Clee S.M., Pimstone S.N. et al. Ethnic variation and in vivo effects of the 93t >g promoter variant in the lipoprotein lipase gene. Arterioscler. Thromb. Vasc. Biol. 17:1997;2672-2678.